Drug intelligence / Profile preview

echinops cephalotes hexane fraction

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

**echinops cephalotes hexane fraction** is a plant-derived research extract obtained from *Echinops cephalotes* and studied in preclinical models of cognitive impairment. It is not a single purified active pharmaceutical ingredient but a **natural product mixture** prepared as a hexane-soluble fraction, and published data indicate **anti-acetylcholinesterase** and **anti-butyrylcholinesterase** activity together with reversal of **scopolamine-induced memory impairment** in mice in behavioral assays. The available evidence supports investigation as an early-stage experimental agent for neurodegenerative and memory-disorder indications, particularly **Alzheimer's disease**, but there is no clear evidence of commercial pharmaceutical development, approved use, or an established brand sponsor.

Other names
echinops cephalotes hexane fractionhexane fraction of echinops cephalotesEchinops cephalotes hexane extractEC hexane fraction
02

Targets

AcetylcholinesteraseButyrylcholinesterase

Beyond the preview

Go deeper on echinops cephalotes hexane fraction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on echinops cephalotes hexane fraction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call